seed
Stage
2018
Founded
3
Investors
About
Orixha develops proprietary Total Liquid Ventilation (TLV) technology aimed at improving clinical outcomes for critical care patients by providing respiratory support through breathable liquids.
Explore Orixha's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.